Department of Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Tübingen, Wilhelmstr. 56, 72074, Tübingen, Germany.
Histochem Cell Biol. 2010 Nov;134(5):469-81. doi: 10.1007/s00418-010-0747-1. Epub 2010 Oct 1.
Signaling through the Wnt/β-catenin pathway is a crucial determinant of hepatic zonal gene expression, liver development, regeneration, and tumorigenesis. Transgenic mice with hepatocyte-specific knockout of Ctnnb1 (encoding β-catenin) have proven their usefulness in elucidating these processes. We now found that a small number of hepatocytes escape the Cre-mediated gene knockout in that mouse model. The remaining β-catenin-positive hepatocytes showed approximately 25% higher cell volumes compared to the β-catenin-negative cells and exhibited a marker protein expression profile similar to that of normal perivenous hepatocytes or hepatoma cells with mutationally activated β-catenin. Surprisingly, the expression pattern was observed independent of the cell's position within the liver lobule, suggesting a malfunction of physiological periportal repression of perivenously expressed genes in β-catenin-deficient liver. Clusters of β-catenin-expressing hepatocytes lacked expression of the gap junction proteins Connexin 26 and 32. Nonetheless, β-catenin-positive hepatocytes had no striking proliferative advantage, but started to grow out on treatment with phenobarbital, a tumor-promoting agent known to facilitate the formation of mouse liver adenoma with activating mutations of Ctnnb1. Progressive re-population of Ctnnb1 knockout livers with wild-type hepatocytes was seen in aged mice with a pre-cirrhotic phenotype. In these large clusters of β-catenin-expressing hepatocytes, perivenous-specific gene expression was re-established. In summary, our data demonstrate that the zone-specificity of a hepatocyte's gene expression profile is dependent on the presence of β-catenin, and that β-catenin provides a proliferative advantage to hepatocytes when promoted with phenobarbital, or in a pre-cirrhotic environment.
Wnt/β-catenin 信号通路的信号传导是肝区基因表达、肝发育、再生和肿瘤发生的关键决定因素。已经证明,具有肝细胞特异性 Ctnnb1(编码β-连环蛋白)基因敲除的转基因小鼠在阐明这些过程方面非常有用。我们现在发现,在该小鼠模型中,少数肝细胞逃脱了 Cre 介导的基因敲除。与β-连环蛋白阴性细胞相比,剩余的β-连环蛋白阳性肝细胞的细胞体积增加了约 25%,并且表现出与正常门静脉周围肝细胞或具有突变激活β-连环蛋白的肝癌细胞相似的标记蛋白表达谱。令人惊讶的是,这种表达模式独立于细胞在肝小叶内的位置,表明在β-连环蛋白缺陷肝中,门静脉周围表达基因的生理门静脉抑制功能失调。β-连环蛋白表达肝细胞簇缺乏间隙连接蛋白 Connexin 26 和 32 的表达。尽管如此,β-连环蛋白阳性肝细胞并没有明显的增殖优势,但在用苯巴比妥(一种已知可促进 Ctnnb1 激活突变的小鼠肝腺瘤形成的促肿瘤剂)治疗时开始生长。在具有预肝硬化表型的老年小鼠中,观察到 Ctnnb1 敲除肝脏中野生型肝细胞的逐渐重新定植。在这些β-连环蛋白表达肝细胞的大簇中,重新建立了门静脉特异性基因表达。总之,我们的数据表明,肝细胞基因表达谱的区域特异性取决于β-连环蛋白的存在,并且当用苯巴比妥或在预肝硬化环境中促进β-连环蛋白时,β-连环蛋白为肝细胞提供增殖优势。